Submitted by amarin on Fri, 12/08/2017 - 04:49
ID Reference
8956
News title
Amarin Announces Submission of Supplemental New Drug Application for Chemport, Inc. as an Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier